Duck Creek Technologies Inc (DCT)

US2641201064 - Common Stock

18.99  0 (0%)

After market: 18.99 0 (0%)

Buy % Consensus

47

ChartMill assigns a Buy % Consensus number of 47% to DCT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 16.47. This target is -13.29% below the current price.
DCT was analyzed by 9 analysts. The buy percentage consensus is at 47. So analysts seem to be rather neutral about DCT.
In the last month the buy percentage fell by 21 points. So the trust of analysts is decreasing.
DCT was analyzed by 9 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 18.9911.1116.3216.4719.95 - -41.50% -14.06% -13.29% 5.06%
Up and Down Grades
Date Firm Action Rating
2023-02-08 DA Davidson Downgrade Buy -> Neutral
2023-01-17 Raymond James Downgrade Outperform -> Market Perform
2023-01-11 Barclays Downgrade Overweight -> Equal-Weight
2023-01-10 William Blair Downgrade Outperform -> Market Perform
2023-01-09 Needham Downgrade Buy -> Hold
2023-01-04 B of A Securities Downgrade Neutral -> Underperform
2022-12-01 JP Morgan Initiate Neutral
2022-10-13 Needham Maintains Buy
2022-10-13 RBC Capital Maintains Sector Perform
2022-10-13 Raymond James Maintains Outperform
2022-10-12 Barclays Maintains Overweight
2022-07-19 RBC Capital Downgrade Outperform -> Sector Perform
2022-07-01 JMP Securities Downgrade Market Outperform -> Market Perform
2022-07-01 B of A Securities Downgrade Buy -> Neutral
2022-06-30 Needham Maintains Buy
2022-06-30 RBC Capital Maintains Outperform
2022-06-30 Barclays Maintains Overweight
2022-06-30 Raymond James Maintains Outperform
2022-01-07 JMP Securities Maintains Market Outperform
2022-01-07 Needham Maintains Buy
2022-01-07 Barclays Maintains Overweight
2022-01-07 Raymond James Maintains Outperform
2021-11-22 Barclays Upgrade Equal-Weight -> Overweight
2021-10-15 RBC Capital Maintains Outperform
2021-10-15 Barclays Maintains Equal-Weight
2021-10-15 Raymond James Maintains Outperform
2021-10-15 JP Morgan Downgrade Overweight -> Neutral
2021-07-13 JP Morgan Upgrade Neutral -> Overweight
2021-04-23 Wolfe Research Initiate Outperform